This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
|Articles|August 18, 2006
Education and CME Trends
Author(s)Tamer A. Seckin, MD
35th Annual Clinical Meeting of Advancing Minimally Invasive Gynecology Worldwide (AAGL)Las Vegas, NV - November 2006
Advertisement
Tamer A. Seckin, MD
872 Fifth Avenue
New York, NY 10021-4953
USA
Phone: 212.988.1444
Fax: 212.988.1755
Email: tamer@deep.net
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of Windows Media Player, available
Advertisement
Related to this article
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Q&A: Peter Hsin, BS, on perioperative ketamine and early postpartum depression
2
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
3
FAQ: Who is a candidate for testosterone therapy in women?
4
FAQ: What does the evidence show about testosterone in women?
5